A detailed history of Cubist Systematic Strategies, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 66,100 shares of ABBV stock, worth $11.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
66,100
Previous 87,400 24.37%
Holding current value
$11.9 Million
Previous $15 Million 12.92%
% of portfolio
0.08%
Previous 0.1%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $15.4 Million - $17.3 Million
111,739 Added 6072.77%
113,579 $17.6 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $17.7 Million - $20.5 Million
-132,338 Reduced 98.63%
1,840 $274,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $17.8 Million - $22.1 Million
134,178 New
134,178 $18.1 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $6.41 Million - $7.69 Million
46,358 Added 836.94%
51,897 $8.39 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $91,799 - $105,288
684 Added 14.09%
5,539 $743,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $8.44 Million - $10.7 Million
-61,314 Reduced 92.66%
4,855 $744,000
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $6.97 Million - $8.64 Million
52,788 Added 394.5%
66,169 $10.7 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $5.37 Million - $6.8 Million
-50,009 Reduced 78.89%
13,381 $1.81 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $2.9 Million - $3.29 Million
-27,254 Reduced 30.07%
63,390 $6.84 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $2.23 Million - $2.48 Million
21,186 Added 30.5%
90,644 $10.2 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $6.55 Million - $7.22 Million
64,072 Added 1189.6%
69,458 $7.52 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $11.3 Million - $15.2 Million
-140,197 Reduced 96.3%
5,386 $577,000
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $7.1 Million - $8.34 Million
82,674 Added 131.42%
145,583 $12.8 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $1.91 Million - $2.56 Million
-26,046 Reduced 29.28%
62,909 $6.18 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $6.96 Million - $10.6 Million
-107,909 Reduced 54.81%
88,955 $6.78 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $2.95 Million - $3.7 Million
-40,942 Reduced 17.22%
196,864 $17.4 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $8.95 Million - $10.8 Million
142,072 Added 148.4%
237,806 $18 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $3.38 Million - $4.32 Million
51,497 Added 116.41%
95,734 $6.96 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $3.12 Million - $3.67 Million
40,412 Added 1056.52%
44,237 $3.57 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $2.16 Million - $2.66 Million
-27,693 Reduced 87.86%
3,825 $353,000
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $1.02 Million - $1.14 Million
-11,512 Reduced 26.75%
31,518 $2.98 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $309,741 - $366,493
3,450 Added 8.72%
43,030 $3.99 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $304,461 - $407,701
-3,309 Reduced 7.72%
39,580 $3.75 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $2.45 Million - $2.69 Million
27,351 Added 176.03%
42,889 $4.15 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.09 Million - $1.39 Million
15,538
15,538 $1.38 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.